5Byington RP, Davis BR, Plehn JF et al, Redction of Stroke Events With Pravastatin. Circulation 2001 ; 103:387-392.
6Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the Development of Diabetes Mellitus. Circulation 2001 ; 357- 362.
7Luc G. Mechanisms of action of hypolipidemic agents,Therapie 2000 ; 55 (6) : 661 - 668.
8Chinetti G, Fruchart JC, Staeles B, Peroxisome prolifera-toractivated receptors(PPARs): nuclear receptors with functions in the vascular wall, Z Kardiol 2001;90 Suppl 3:125-132.
9Steinmez A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes 2001 ; 109(4) :548- 559.
10Rubbins H B, Roins S J, Collins D, et al. Gemfibrozil for the second prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group,NEngl J Med 1999;341:410-418.
